Choksi Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 525405,
    "name": "Choksi Laborator",
    "stock_name": "Choksi Laborator",
    "full_name": "Choksi Laboratories Ltd",
    "name_url": "stocks-analysis/choksi-laborator",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "98.40",
    "chg": 1.5,
    "chgp": "1.55%",
    "dir": 1,
    "prev_price": "96.90",
    "mcapval": "66.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526546,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE493D01013",
    "curr_date": "Apr 15",
    "curr_time": "",
    "bse_nse_vol": "6.31 k",
    "exc_status": "Active",
    "traded_date": "Apr 15, 2026",
    "traded_date_str": "2026 04 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/choksi-laborator-525405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvement and Valuation Appeal",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvement-and-valuation-appeal-3945143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3945143.png",
        "date": "2026-04-14 08:07:19",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook, even as its fundamental and financial metrics remain under pressure. The revised rating highlights a mild improvement in technical indicators, balanced against persistent challenges in valuation and financial trends."
      },
      {
        "title": "Choksi Laboratories Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-weakness-3936456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3936456.png",
        "date": "2026-04-08 08:03:13",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has been downgraded from a Sell to a Strong Sell rating as of 7 April 2026. The downgrade reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, signalling caution for investors amid challenging market conditions."
      },
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-flat-financials-3929568",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3929568.png",
        "date": "2026-04-02 08:03:11",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing fundamental challenges, signalling a cautious but slightly more optimistic stance from analysts."
      },
      {
        "title": "Choksi Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3923432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_mojoScore_3923432.png",
        "date": "2026-03-30 08:02:02",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 27 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and ongoing valuation concerns, signalling heightened risks for investors amid a challenging market environment."
      },
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvement Despite Fundamental Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvement-despite-fundamental-challenges-3906280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_mojoScore_3906280.png",
        "date": "2026-03-23 08:01:13",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 March 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental challenges, prompting a reassessment of its valuation and market positioning."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-strong-sell-3893139",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_mojoScore_3893139.png",
        "date": "2026-03-16 10:10:47",
        "description": "Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Choksi Laboratories Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/choksi-laboratories-ltd-falls-to-52-week-low-amidst-continued-downtrend-3869952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_priceRelatedfactors_3869952.png",
        "date": "2026-03-04 12:44:53",
        "description": "Choksi Laboratories Ltd, a player in the Healthcare Services sector, has touched a new 52-week low of Rs.81.85 today, marking a significant decline amid ongoing market pressures and sector underperformance. The stock’s recent performance highlights persistent challenges reflected in its valuation and financial metrics."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-strong-sell-3868816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_mojoScore_3868816.png",
        "date": "2026-03-04 10:10:55",
        "description": "Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Choksi Laboratories Downgraded to Strong Sell Amid Technical and Fundamental Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-downgraded-to-strong-sell-amid-technical-and-fundamental-weakness-3845166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ChoksiLaborator_mojoScore_3845166.png",
        "date": "2026-02-18 08:03:51",
        "description": "Choksi Laboratories Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 17 Feb 2026. This shift reflects deteriorating technical indicators, stagnant financial performance, and a challenging valuation backdrop, signalling caution for investors amid underwhelming market returns and weak fundamental metrics."
      }
    ],
    "total": 292,
    "sid": "525405",
    "stock_news_url": "https://www.marketsmojo.com/news/choksi-laboratories-525405"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Submission of Certificate issued by RTA under Regulation 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-Mar-2026",
      "details": "Intimation for newspaper publication of information related to Postal ballot notice and e-voting process",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation for closure of trading window w.e.f. 01.04.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Choksi Laboratories Ltd Upgraded to Sell on Technical Improvement and Valuation Appeal

2026-04-14 08:07:19

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook, even as its fundamental and financial metrics remain under pressure. The revised rating highlights a mild improvement in technical indicators, balanced against persistent challenges in valuation and financial trends.

Read full news article

Choksi Laboratories Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weakness

2026-04-08 08:03:13

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has been downgraded from a Sell to a Strong Sell rating as of 7 April 2026. The downgrade reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, signalling caution for investors amid challenging market conditions.

Read full news article

Choksi Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials

2026-04-02 08:03:11

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing fundamental challenges, signalling a cautious but slightly more optimistic stance from analysts.

Read full news article

Choksi Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-03-30 08:02:02

Choksi Laboratories Ltd, a micro-cap player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 27 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and ongoing valuation concerns, signalling heightened risks for investors amid a challenging market environment.

Read full news article

Choksi Laboratories Ltd Upgraded to Sell on Technical Improvement Despite Fundamental Challenges

2026-03-23 08:01:13

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 March 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental challenges, prompting a reassessment of its valuation and market positioning.

Read full news article

Choksi Laboratories Ltd is Rated Strong Sell

2026-03-16 10:10:47

Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Choksi Laboratories Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-03-04 12:44:53

Choksi Laboratories Ltd, a player in the Healthcare Services sector, has touched a new 52-week low of Rs.81.85 today, marking a significant decline amid ongoing market pressures and sector underperformance. The stock’s recent performance highlights persistent challenges reflected in its valuation and financial metrics.

Read full news article

Choksi Laboratories Ltd is Rated Strong Sell

2026-03-04 10:10:55

Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Choksi Laboratories Downgraded to Strong Sell Amid Technical and Fundamental Weakness

2026-02-18 08:03:51

Choksi Laboratories Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 17 Feb 2026. This shift reflects deteriorating technical indicators, stagnant financial performance, and a challenging valuation backdrop, signalling caution for investors amid underwhelming market returns and weak fundamental metrics.

Read full news article

View All News